Life Technologies Corporation announced the launch of its next-generation, high throughput genotypic MicroSEQ® Microbial ID System for the identification of bacteria and fungi within a pharmaceutical manufacturing environment. Powered by the new 3500 Series Genetic Analyzer, this new system offers enhanced throughput, ease-of-use features while maintaining the accuracy required by the pharmaceutical industry to rapidly identify microbial contaminations. To review their entire press release, please visit our RMM News Page at http://rapidmicromethods.com/files/news.html.
- Scientific Principles
- _Growth-based Methods
- _Viability Staining and Laser Excitation
- _Detection of Cellular Components
- _Optical Spectroscopy
- _Nucleic Acid Amplification
- _MEMs
- Product Matrix
- Validate
- Regulatory
- _Annex 1 Revision
- _Rapid Sterility Testing of ATMPs
- _Changing Acceptance Levels
- _US Food and Drug Administration (FDA)
- _European Medicines Agency (EMA)
- _Australia TGA
- _Japan PMDA
- Recent Posts